These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 11209978

  • 1. Antiphospholipid antibodies in arterial thrombosis.
    Koike T.
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 4. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 6. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 7. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM.
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [Abstract] [Full Text] [Related]

  • 8. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [Abstract] [Full Text] [Related]

  • 9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J.
    Verh K Acad Geneeskd Belg; 2000 Jun; 62(5):353-72. PubMed ID: 11144685
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA.
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA, van Oort E, Tempelman MJ, Derksen RH, de Groot PG.
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR.
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [Abstract] [Full Text] [Related]

  • 14. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 15. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM, Derksen RV, Alekberova ZS, Horbach D, De Groot F, Nasonov EL, Kalashnikova LA, Match ES, Nasonova VA.
    Klin Med (Mosk); 1998 Nov; 76(3):36-40. PubMed ID: 9575746
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B.
    Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
    [Abstract] [Full Text] [Related]

  • 18. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG, Smith SA.
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [Abstract] [Full Text] [Related]

  • 19. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL, Leung S, Miller-Blair DJ, Ziboh V.
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [Abstract] [Full Text] [Related]

  • 20. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E.
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.